Maternal mortality rates in the United States exceed those of other developed countries, with some considerable racial disparities. Black mothers have three to four times the risk compared to white mothers, while more than half of these deaths are deemed to be preventable. Public health interventions attempt to improve maternal health and pregnancy outcomes, and a new study from researchers at Florida Atlantic University indicates those programs are making a difference.
The rigorous study using longitudinal data from Florida counties for 2001-2014 finds strong evidence that targeted pregnancy-related public health programs are effective at reducing maternal mortality rates, specifically among black mothers.
The study conducted by FAU College of Business faculty members Patrick Bernet, Ph.D., Gulcin Gumus, Ph.D., and Sharmila Vishwasrao, Ph.D., and recently published in the journal The Milbank Quarterly , found that spending on public health significantly reduced the maternal mortality rate among black mothers and narrowed black-white outcome disparities. Each 10 percent increase in pregnancy-related public health expenditures was associated with a 13.5 percent decline in the maternal mortality rate among blacks and a 20 percent reduction in black-white disparities.
Clearly, it's a pretty extreme outcome, and to find that relatively small expenditures can affect something like maternal death is very surprising. It's not just an extreme outcome, it's also kind of rare. There seems to have been unfortunately a sharp increase in maternal mortality in the U.S. over the last two decades or so, but it's still a rare event. Combine that with the fact that this is a very extreme outcome for women who at some point during their pregnancy are under physician control, that's a big deal, in fact." Gulcin Gumus, associate professor in health administration in FAU's Department of Management Programs Related Stories
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology